News | December 26, 2023
BioVaxys executes LoI for major Immunotherapeutics technology acquisition
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
South Asia’s largest exhibition for pharma brought together over 50,000 visitors from across the globe
Subscribe To Our Newsletter & Stay Updated
